{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Ageratina pichinchensis", "Arthrospira maxima", "Complementary and alternative medicine", "Onychomycosis", "Tea tree oil"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "35983465", "DateRevised": {"Year": "2023", "Month": "07", "Day": "03"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2022", "Month": "02", "Day": "09"}], "ELocationID": ["10.1159/000521703"], "Journal": {"ISSN": "2296-9195", "JournalIssue": {"Volume": "8", "Issue": "4", "PubDate": {"Year": "2022", "Month": "Jul"}}, "Title": "Skin appendage disorders", "ISOAbbreviation": "Skin Appendage Disord"}, "ArticleTitle": "Complementary and Alternative Therapies for Onychomycosis: A Systematic Review of the Clinical Evidence.", "Pagination": {"StartPage": "269", "EndPage": "279", "MedlinePgn": "269-279"}, "Abstract": {"AbstractText": ["Onychomycosis is notoriously difficult to treat. While oral antifungals are the most efficacious treatment for onychomycosis, they are contraindicated in certain patient populations, and patients may desire lower risk and accessible alternatives to systemic agents. In this study, we examine the clinical evidence supporting the use of complementary and alternative therapies in the treatment of onychomycosis.", "PubMed, Embase, and Cochrane Library were searched for clinical trials, observational studies, and case reports/case series, examining the efficacy of a complementary or alternative therapy for the treatment of onychomycosis.", "We identified 17 articles studying a complementary and alternative therapy for onychomycosis, including tea tree oil (<i>n</i> = 5), <i>Ageratina pichinchensis</i> (<i>n</i> = 3), <i>Arthrospira maxima</i> (<i>n</i> = 2), natural coniferous resin lacquer (<i>n</i> = 2), Vicks VapoRub<sup>\u00ae</sup> (<i>n</i> = 2), propolis extract (<i>n</i> = 2), and ozonized sunflower oil (<i>n</i> = 1).", "Given the rise of antifungal resistance, complementary and alternative therapies should continue to be studied as adjunctive or alternative therapy for onychomycosis. While preliminary evidence exists for several complementary and alternative therapies in the treatment of onychomycosis, large-scale, randomized, placebo-controlled trials are needed prior to endorsing their use to patients."], "CopyrightInformation": "Copyright \u00a9 2022 by S. Karger AG, Basel."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Illinois at Chicago College of Medicine, Chicago, Illinois, USA."}], "LastName": "Nickles", "ForeName": "Melissa A", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA."}, {"Identifier": [], "Affiliation": "Medical Dermatology Associates of Chicago, Chicago, Illinois, USA."}], "LastName": "Lio", "ForeName": "Peter A", "Initials": "PA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA."}], "LastName": "Mervak", "ForeName": "Julie E", "Initials": "JE"}], "PublicationTypeList": ["Systematic Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Skin Appendage Disord", "NlmUniqueID": "101670617", "ISSNLinking": "2296-9160"}, "CoiStatement": "The authors have no conflicts of interest to declare."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Gupta AK, Jain HC, Lynde CW, Macdonald P, Cooper EA, Summerbell RC. Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: a multicenter canadian survey of 15,000 patients. J Am Acad Dermatol. 2000 Aug;43((2 Pt 1)):244\u20138.", "ArticleIdList": ["10906646"]}, {"Citation": "Lipner SR, Scher RK. Onychomycosis: clinical overview and diagnosis. J Am Acad Dermatol. 2019 Apr;80((4)):835\u201351.", "ArticleIdList": ["29959961"]}, {"Citation": "Gupta AK, Stec N. Emerging drugs for the treatment of onychomycosis. Expert Opin Emerg Drugs. 2019 Dec;24((4)):213\u201320.", "ArticleIdList": ["31652088"]}, {"Citation": "Gupta AK, Renaud HJ, Quinlan EM, Shear NH, Piguet V. The growing problem of antifungal resistance in onychomycosis and other superficial mycoses. Am J Clin Dermatol. 2021 Mar;22((2)):149\u201357.", "ArticleIdList": ["33354740"]}, {"Citation": "Phan K, Kaur K, Wright K, Tran S, Stewart B, Brown M, et al. The penetrance of topical nail therapy: limitations and current enhancements. Clin Podiatr Med Surg. 2021 Oct;38((4)):535\u201340.", "ArticleIdList": ["34538431"]}, {"Citation": "Elewski B, Tavakkol A. Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality. Ther Clin Risk Manag. 2005 Dec;1((4)):299\u2013306.", "ArticleIdList": ["PMC1661633", "18360572"]}, {"Citation": "Complementary & alternative medicine The Dermatologist. 2008;16((4))"}, {"Citation": "Flores FC, Beck RC, da Silva Cde B. Essential oils for treatment for onychomycosis: a mini-review. Mycopathologia. 2016 Feb;181((1\u20132)):9\u201315.", "ArticleIdList": ["26481920"]}, {"Citation": "Halteh P, Scher RK, Lipner SR. Over-the-counter and natural remedies for onychomycosis: do they really work? Cutis. 2016 Nov;98((5)):E16\u2013e25.", "ArticleIdList": ["28040821"]}, {"Citation": "Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996 Feb;17((1)):1\u201312.", "ArticleIdList": ["8721797"]}, {"Citation": "Freeman AM, Freeman MG. Nailkalm (Arthrospira maxima) for the treatment of dermatophyte nail infections. Aus J Dermatol. 2011;52:25."}, {"Citation": "Men\u00e9ndez S, Falc\u00f3n L, Maqueira Y. Therapeutic efficacy of topical Oleozon\u00ae in patients suffering from onychomycosis. Mycoses. 2011;54((5)):e272\u20107.", "ArticleIdList": ["20492527"]}, {"Citation": "Parekh M, Ramaiah G, Pashilkar P, Ramanujam R, Johnston P, Ilag LL. A pilot single centre, double blind, placebo controlled, randomized, parallel study of Calmagen\u00ae dermaceutical cream and lotion for the topical treatment of tinea and onychomycosis. BMC Complement Altern Med. 2017;17((1)):464.", "ArticleIdList": ["PMC5604504", "28923039"]}, {"Citation": "Snell M, Klebert M, \u00d6nen NF, Hubert S. A novel treatment for onychomycosis in people living with HIV infection: vicks vaporub\u2122 is effective and safe. J Assoc Nurses AIDS Care. 2016;27((1)):109\u201313.", "ArticleIdList": ["26585031"]}, {"Citation": "Romero-Cerecero O, Islas-Gardu\u00f1o AL, Zamilpa A, Tortoriello J. Effectiveness of an encecalin standardized extract of Ageratina pichinchensis on the treatment of onychomycosis in patients with diabetes mellitus. Phytother Res. 2020;34((7)):1678\u201386.", "ArticleIdList": ["32086985"]}, {"Citation": "Syed TA, Qureshi ZA, Ali SM, Ahmad S, Ahmad SA. Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream. Trop Med Int Health. 1999;4((4)):284\u20137.", "ArticleIdList": ["10357864"]}, {"Citation": "Sipponen P, Sipponen A, Lohi J, Soini M, Tapanainen R, Jokinen JJ. Natural coniferous resin lacquer in treatment of toenail onychomycosis: an observational study. Mycoses. 2013;56((3)):289\u201396.", "ArticleIdList": ["PMC3666097", "23131104"]}, {"Citation": "Auvinen T, Tiihonen R, Soini M, Wangel M, Sipponen A, Jokinen JJ. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial. Br J Dermatol. 2015;173((4)):940\u20138.", "ArticleIdList": ["26036329"]}, {"Citation": "Derby R, Rohal P, Jackson C, Beutler A, Olsen C. Novel treatment of onychomycosis using over-the-counter mentholated ointment: a clinical case series. J Am Board Fam Med. 2011;24((1)):69\u201374.", "ArticleIdList": ["21209346"]}, {"Citation": "AbdelHamid D, Gomaa AHA, Mohammed GF, Eyada MMK, El Sweify MA. Evaluation of the therapeutic efficacy of tea tree oil in treatment of onychomycosis. Int J Pharmacogn Phytochem Res. 2017;9((12)):1414\u201320."}, {"Citation": "Veiga FF, Costa MI, C\u00f3tica SK, Svidzinski TIE, Negri M. Propolis for the treatment of onychomycosis. Indian J Dermatol. 2018 Nov;63((6)):515\u20137.", "ArticleIdList": ["PMC6233048", "30504984"]}, {"Citation": "Alessandrini A, Starace M, Bruni F, Piraccini BM. An open study to evaluate effectiveness and tolerability of a nail oil composed of vitamin e and essential oils in mild to moderate distal subungual onychomycosis. Skin Appendage Disord. 2020;6((1)):14\u20138.", "ArticleIdList": ["PMC6995982", "32021856"]}, {"Citation": "Romero-Cerecero O, Rom\u00e1n-Ramos R, Zamilpa A, Jim\u00e9nez-Ferrer JE, Rojas-Bribiesca G, Tortoriello J. Clinical trial to compare the effectiveness of two concentrations of the Ageratina pichinchensis extract in the topical treatment of onychomycosis. J Ethnopharmacol. 2009;126((1)):74\u20138.", "ArticleIdList": ["19683043"]}, {"Citation": "Pazyar N, Yaghoobi R, Bagherani N, Kazerouni A. A review of applications of tea tree oil in dermatology. Int J Dermatol. 2013 Jul;52((7)):784\u201390.", "ArticleIdList": ["22998411"]}, {"Citation": "Vastarella M, Ferrillo M, Donnarumma M, Gallo L, Delfino M, Fabbrocini G. Efficacy of a protective nail product composed by vitamin e and essential oils of lime, oregano and tea tree for treatment of nail onychomycosis. J Dermatol Nurs Assoc. 2020;12((2)):10."}, {"Citation": "Buck DS, Nidorf DM, Addino JG. Comparison of two topical preparations for the treatment of onychomycosis: melaleuca alternifolia (tea tree) oil and clotrimazole. J Fam Pract. 1994;38((6)):601\u20135.", "ArticleIdList": ["8195735"]}, {"Citation": "Aguilar-Guadarrama B, Navarro V, Le\u00f3n-Rivera I, Rios MY. Active compounds against tinea pedis dermatophytes from Ageratina pichinchensis var. bustamenta. Nat Prod Res. 2009;23((16)):1559\u201365.", "ArticleIdList": ["19844829"]}, {"Citation": "Romero-Cerecero O, Rojas G, Navarro V, Herrera-Arellano A, Zamilpa-Alvarez A, Tortoriello J. Effectiveness and tolerability of a standardized extract from Ageratina pichinchensis on patients with tinea pedis: an explorative pilot study controlled with ketoconazole. Planta Med. 2006 Nov;72((14)):1257\u201361.", "ArticleIdList": ["17051456"]}, {"Citation": "Romero-Cerecero O, Zamilpa A, Jim\u00e9nez-Ferrer E, Tortoriello J. Therapeutic effectiveness of Ageratina pichinchensis on the treatment of chronic interdigital tinea pedis: a randomized, double-blind clinical trial. J Altern Complement Med. 2012 Jun;18((6)):607\u201311.", "ArticleIdList": ["22784348"]}, {"Citation": "Romero-Cerecero O, Zamilpa A, Jim\u00e9nez-Ferrer JE, Rojas-Bribiesca G, Rom\u00e1n-Ramos R, Tortoriello J. Double-blind clinical trial for evaluating the effectiveness and tolerability of Ageratina pichinchensis extract on patients with mild to moderate onychomycosis. A comparative study with ciclopirox. Planta Med. 2008;74((12)):1430\u20135.", "ArticleIdList": ["18671197"]}, {"Citation": "Vo TS, Ngo DH, Kim SK. Nutritional and pharmaceutical properties of microalgal spirulina. In: Kim SK, editor. Handbook of marine microalgae. Boston: Academic Press; 2015. pp. p. 299\u2013308."}, {"Citation": "Nowicka-Krawczyk P, M\u00fchlsteinov\u00e1 R, Hauer T. Detailed characterization of the arthrospira type species separating commercially grown taxa into the new genus limnospira (Cyanobacteria) Sci Rep. 2019 Jan 24;9((1)):694.", "ArticleIdList": ["PMC6345927", "30679537"]}, {"Citation": "Duncan KW, Brown AM. Arthrospira-based compositions and uses thereof. WO 2006047830 A1 patent. 2006"}, {"Citation": "Sipponen A, Peltola R, Jokinen JJ, Laitinen K, Lohi J, Rautio M, et al. Effects of norway spruce (Picea abies) resin on cell wall and cell membrane of Staphylococcus aureus. Ultrastruct Pathol. 2009;33((3)):128\u201335.", "ArticleIdList": ["19479653"]}, {"Citation": "Rautio M, Sipponen A, Lohi J, Lounatmaa K, Koukila-K\u00e4hk\u00f6l\u00e4 P, Laitinen K. In vitro fungistatic effects of natural coniferous resin from Norway spruce (Picea abies) Eur J Clin Microbiol Infect Dis. 2012 Aug;31((8)):1783\u20139.", "ArticleIdList": ["22179415"]}, {"Citation": "Men\u00e9ndez S, Falc\u00f3n L, Sim\u00f3n DR, Landa N. Efficacy of ozonized sunflower oil in the treatment of tinea pedis. Mycoses. 2002 Oct;45((8)):329\u201332.", "ArticleIdList": ["12572723"]}, {"Citation": "Guerrer LV, Cunha KC, Nogueira MC, Cardoso CC, Soares MM, Almeida MT. \u201cIn vitro\u201d antifungal activity of ozonized sunflower oil on yeasts from onychomycosis. Braz J Microbiol. 2012 Oct;43((4)):1315\u20138.", "ArticleIdList": ["PMC3769014", "24031958"]}, {"Citation": "Li H, Guo M, Wang C, Li Y, Fernandez AM, Ferraro TN, et al. Epidemiological study of Trichosporon asahii infections over the past 23 years. Epidemiol Infect. 2020 Jul 24;148:e169.", "ArticleIdList": ["PMC7439294", "32703332"]}, {"Citation": "Tobaldini-Valerio FK, Bonfim-Mendon\u00e7a PS, Rosseto HC, Bruschi ML, Henriques M, Negri M, et al. Propolis: a potential natural product to fight Candida species infections. Future Microbiol. 2016 Aug;11:1035\u201346.", "ArticleIdList": ["27501739"]}, {"Citation": "Veiga FF, Gadelha MC, da Silva MRT, Costa MI, Kischkel B, de Castro-Hoshino LV, et al. Propolis extract for onychomycosis topical treatment: from bench to clinic. Front Microbiol. 2018;9:759.", "ArticleIdList": ["PMC5996904", "29922236"]}, {"Citation": "Ramsewak RS, Nair MG, Stommel M, Selanders L. In vitro antagonistic activity of monoterpenes and their mixtures against \u201ctoe nail fungus\u201d pathogens. Phytother Res. 2003;17((4)):376\u20139.", "ArticleIdList": ["12722144"]}, {"Citation": "FAQS Vapo Proctor & gamble. 2021."}, {"Citation": "Gupta P, Pruthi V, Poluri KM. Mechanistic insights into Candida biofilm eradication potential of eucalyptol. J Appl Microbiol. 2021 Jul;131((1)):105\u201323.", "ArticleIdList": ["33226719"]}, {"Citation": "Ivanov M, Kannan A, Stojkovi\u0107 DS, Glamo\u010dlija J, Calhelha RC, Ferreira I, et al. Camphor and eucalyptol-anticandidal spectrum, antivirulence effect, efflux pumps interference and cytotoxicity. Int J Mol Sci. 2021 Jan 6;((2)):22.", "ArticleIdList": ["PMC7825113", "33418931"]}, {"Citation": "Bodman MAKK. StatPearls [Internet] Treasure Island, FL: StatPearls Publishing; 2021."}, {"Citation": "Bunyaratavej S, Srinonprasert V, Kiratiwongwan R, Wongdama S, Leeyaphan C. Onychomycosis in older adults: the age and associated factors affecting the complete cure rate. Australas J Dermatol. 2021 Aug 16", "ArticleIdList": ["34398469"]}, {"Citation": "Haugh M, Helou S, Boissel JP, Cribier BJ. Terbinafine in fungal infections of the nails: a meta-analysis of randomized clinical trials. Br J Dermatol. 2002 Jul;147((1)):118\u201321.", "ArticleIdList": ["12100193"]}, {"Citation": "Gupta AK, Ryder J, Summerbell RC. Comparison of efficacy criteria across onychomycosis trials: need for standardization. Int J Dermatol. 2003 Apr;42((4)):312\u20135.", "ArticleIdList": ["12694503"]}, {"Citation": "Scher RK, Tavakkol A, Sigurgeirsson B, Hay RJ, Joseph WS, Tosti A, et al. Onychomycosis: diagnosis and definition of cure. J Am Acad Dermatol. 2007 Jun;56((6)):939\u201344.", "ArticleIdList": ["17307276"]}, {"Citation": "Shemer A, Daniel R, Rigopoulos D, Farhi R, Babaev M. Variability in systemic treatment efficacy for onychomycosis: information that clinical studies do not impart to the office dermatologist. Skin Appendage Disord. 2018;4((3)):141\u20134.", "ArticleIdList": ["PMC6120383", "30197889"]}, {"Citation": "Gupta AK, Summerbell RC, Venkataraman M, Quinlan EM. Nondermatophyte mould onychomycosis. J Eur Acad Dermatol Venereol. 2021 Aug;35((8)):1628\u201341.", "ArticleIdList": ["33763903"]}, {"Citation": "Gupta AK, Venkataraman M, Renaud HJ, Summerbell R, Shear NH, Piguet V. A paradigm shift in the treatment and management of onychomycosis. Skin Appendage Disord. 2021 Aug;7((5)):351\u20138.", "ArticleIdList": ["PMC8436613", "34604322"]}, {"Citation": "Gupta AK, Daigle D, Carviel JL. The role of biofilms in onychomycosis. J Am Acad Dermatol. 2016;74((6)):1241\u20136.", "ArticleIdList": ["27012826"]}, {"Citation": "Castillo C, Masi MF, Mishko A, Sheltzer A, Speer A, Tran H, et al. Biofilms and the nail unit. Clin Podiatr Med Surg. 2021 Oct;38((4)):529\u201333.", "ArticleIdList": ["34538430"]}, {"Citation": "Machado Vila TV, Sousa Quintanilha N, Rozental S. Miltefosine is effective against Candida albicans and Fusarium oxysporum nail biofilms in vitro. J Med Microbiol. 2015 Nov;64((11)):1436\u201349.", "ArticleIdList": ["26404553"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "10", "Day": "28"}, {"Year": "2021", "Month": "11", "Day": "30"}, {"Year": "2022", "Month": "8", "Day": "19", "Hour": "2", "Minute": "21"}, {"Year": "2022", "Month": "8", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "8", "Day": "20", "Hour": "6", "Minute": "1"}, {"Year": "2023", "Month": "7", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35983465", "PMC9274952", "10.1159/000521703", "sad-0008-0269"]}}], "PubmedBookArticle": []}